Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does AZITHROMYCIN Cause Product prescribing issue? 10 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Product prescribing issue have been filed in association with AZITHROMYCIN (AZITHROMYCIN). This represents 0.1% of all adverse event reports for AZITHROMYCIN.

10
Reports of Product prescribing issue with AZITHROMYCIN
0.1%
of all AZITHROMYCIN reports
1
Deaths
3
Hospitalizations

How Dangerous Is Product prescribing issue From AZITHROMYCIN?

Of the 10 reports, 1 (10.0%) resulted in death, 3 (30.0%) required hospitalization.

Is Product prescribing issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for AZITHROMYCIN. However, 10 reports have been filed with the FAERS database.

What Other Side Effects Does AZITHROMYCIN Cause?

Off label use (2,979) Drug ineffective (2,609) Drug hypersensitivity (1,978) Dyspnoea (1,409) Condition aggravated (1,063) Nausea (1,006) Asthma (972) Wheezing (951) Product use in unapproved indication (886) Cough (837)

What Other Drugs Cause Product prescribing issue?

DUPILUMAB (1,715) POLYETHYLENE GLYCOL 3350 (1,439) LENALIDOMIDE (948) OXYCODONE (646) RIVAROXABAN (359) ACETAMINOPHEN\OXYCODONE (347) ETONOGESTREL (311) ACETAMINOPHEN\HYDROCODONE (298) CERTOLIZUMAB PEGOL (297) CABOZANTINIB S-MALATE (294)

Which AZITHROMYCIN Alternatives Have Lower Product prescribing issue Risk?

AZITHROMYCIN vs AZITHROMYCIN ANHYDROUS AZITHROMYCIN vs AZITHROMYCIN OR METHOTREXATE AZITHROMYCIN vs AZOSEMIDE AZITHROMYCIN vs AZTREONAM AZITHROMYCIN vs AZTREONAM LYSINE

Related Pages

AZITHROMYCIN Full Profile All Product prescribing issue Reports All Drugs Causing Product prescribing issue AZITHROMYCIN Demographics